Malaysia · Delayed Price · Currency is MYR Genting Malaysia Berhad Statistics
Total Valuation
KLSE:GENM has a market cap or net worth of MYR 10.66 billion. The enterprise value is 22.56 billion.
| Market Cap | 10.66B |
| Enterprise Value | 22.56B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | Mar 13, 2026 |
Share Statistics
KLSE:GENM has 5.67 billion shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 5.67B |
| Shares Outstanding | 5.67B |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.94% |
| Owned by Institutions (%) | 5.01% |
| Float | 1.43B |
Valuation Ratios
The trailing PE ratio is 15.70 and the forward PE ratio is 20.56. KLSE:GENM's PEG ratio is 2.50.
| PE Ratio | 15.70 |
| Forward PE | 20.56 |
| PS Ratio | 0.88 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 2.22 |
| P/FCF Ratio | 16.34 |
| P/OCF Ratio | 6.11 |
| PEG Ratio | 2.50 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.19, with an EV/FCF ratio of 34.60.
| EV / Earnings | 33.26 |
| EV / Sales | 1.86 |
| EV / EBITDA | 8.19 |
| EV / EBIT | 16.13 |
| EV / FCF | 34.60 |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 1.67.
| Current Ratio | 0.88 |
| Quick Ratio | 0.82 |
| Debt / Equity | 1.67 |
| Debt / EBITDA | 6.12 |
| Debt / FCF | 26.30 |
| Interest Coverage | 1.87 |
Financial Efficiency
Return on equity (ROE) is 5.63% and return on invested capital (ROIC) is 4.60%.
| Return on Equity (ROE) | 5.63% |
| Return on Assets (ROA) | 2.98% |
| Return on Invested Capital (ROIC) | 4.60% |
| Return on Capital Employed (ROCE) | 5.55% |
| Weighted Average Cost of Capital (WACC) | 4.59% |
| Revenue Per Employee | 677,894 |
| Profits Per Employee | 37,826 |
| Employee Count | 17,932 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 44.99 |
Taxes
In the past 12 months, KLSE:GENM has paid 250.60 million in taxes.
| Income Tax | 250.60M |
| Effective Tax Rate | 29.69% |
Stock Price Statistics
The stock price has increased by +2.17% in the last 52 weeks. The beta is 0.48, so KLSE:GENM's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +2.17% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 2.06 |
| Relative Strength Index (RSI) | 37.40 |
| Average Volume (20 Days) | 1,485,965 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:GENM had revenue of MYR 12.16 billion and earned 678.30 million in profits. Earnings per share was 0.12.
| Revenue | 12.16B |
| Gross Profit | 3.34B |
| Operating Income | 1.44B |
| Pretax Income | 844.10M |
| Net Income | 678.30M |
| EBITDA | 2.68B |
| EBIT | 1.44B |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 4.34 billion in cash and 17.15 billion in debt, with a net cash position of -12.80 billion or -2.26 per share.
| Cash & Cash Equivalents | 4.34B |
| Total Debt | 17.15B |
| Net Cash | -12.80B |
| Net Cash Per Share | -2.26 |
| Equity (Book Value) | 10.26B |
| Book Value Per Share | 1.97 |
| Working Capital | -714.80M |
Cash Flow
In the last 12 months, operating cash flow was 1.74 billion and capital expenditures -1.09 billion, giving a free cash flow of 652.00 million.
| Operating Cash Flow | 1.74B |
| Capital Expenditures | -1.09B |
| Depreciation & Amortization | 1.24B |
| Net Borrowing | 2.72B |
| Free Cash Flow | 652.00M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 27.50%, with operating and profit margins of 11.88% and 5.58%.
| Gross Margin | 27.50% |
| Operating Margin | 11.88% |
| Pretax Margin | 6.94% |
| Profit Margin | 5.58% |
| EBITDA Margin | 22.09% |
| EBIT Margin | 11.88% |
| FCF Margin | 5.36% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 3.70%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 3.70% |
| Dividend Growth (YoY) | -30.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 33.42% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 3.82% |
| Earnings Yield | 6.37% |
| FCF Yield | 6.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for KLSE:GENM is 2.36, which is 25.53% higher than the current price. The consensus rating is "Buy".
| Price Target | 2.36 |
| Price Target Difference | 25.53% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 9.70% |
| EPS Growth Forecast (3Y) | -0.49% |
Stock Splits
The last stock split was on April 11, 2007. It was a forward split with a ratio of 5.
| Last Split Date | Apr 11, 2007 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KLSE:GENM has an Altman Z-Score of 1.21 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.21 |
| Piotroski F-Score | 6 |